Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urinary Bladder Neoplasms × dabrafenib × Clear all

Sponsor

Conditions

Melanoma 29 Neoplasms 10 Brain Neoplasms 6 Neoplasm Metastasis 3 Thyroid Neoplasms 2 Thyroid Cancer, Papillary 2 Skin Neoplasms 2 Glioma 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Carcinoma, Anaplastic 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Neurofibroma, Plexiform 1 Neurocytoma 1 Neuroblastoma 1 Multiple Myeloma 1 Leukemia, Hairy Cell 1 Histiocytosis, Langerhans-Cell 1 Hematologic Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Ganglioneuroma 1 Ganglioglioma 1 Fever 1 Colorectal Neoplasms 1 Biliary Tract Neoplasms 1 Astrocytoma 1 Ameloblastoma 1 Adenocarcinoma, Follicular 1

Interventions

Gemcitabine 47 Cisplatin 32 pembrolizumab 28 Paclitaxel 13 Docetaxel 13 avelumab 12 Mitomycin 12 atezolizumab 11 Nivolumab 11 Cystectomy 9 Carboplatin 9 durvalumab 7 Sunitinib 7 apaziquone 6 Doxorubicin 6 BCG Vaccine 6 5-aminolevulinic acid hexyl ester 6 Vinblastine 5 Platinum 5 Methotrexate 5 Magnetic Resonance Spectroscopy 5 Albumin-Bound Paclitaxel 5 Taxes 4 Standard of Care 4 Sorafenib 4 Radiotherapy 4 Radiation 4 Fluorouracil 4 Erlotinib Hydrochloride 4 1,2-diaminocyclohexaneplatinum II citrate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡